The NIIMBL mission is to accelerate biopharmaceutical manufacturing innovation, support the development of standards.
National Institute for Innovation in Manufacturing Biopharmaceuticals has raised $10.5M in total funding. The most recent round was Grant. The last funding was announced in October 2025.
National Institute for Innovation in Manufacturing Biopharmaceuticals's investors include Bill & Melinda Gates Foundation, National Institute of Standards and Technology.
National Institute for Innovation in Manufacturing Biopharmaceuticals is headquartered in Newark, United States.
The NIIMBL mission is to accelerate biopharmaceutical manufacturing innovation, support the development of standards.
National Institute for Innovation in Manufacturing Biopharmaceuticals is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"National Institute for Innovation in Manufacturing Biopharmaceuticals — Funding & Investors." VCBacked, October 23, 2025, https://www.vcbacked.co/company/national-institute-for-innovation-in-manufacturing-biopharmaceuticals. Accessed August 14, 2026.
VCBacked. (2025). National Institute for Innovation in Manufacturing Biopharmaceuticals — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/national-institute-for-innovation-in-manufacturing-biopharmaceuticals
{{cite web |title=National Institute for Innovation in Manufacturing Biopharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/national-institute-for-innovation-in-manufacturing-biopharmaceuticals |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated